tradingkey.logo

GeneDx Holdings Corp

WGS
91.240USD
+6.950+8.25%
收盤 02/09, 16:00美東報價延遲15分鐘
653.12M總市值
840.77本益比TTM

GeneDx Holdings Corp

91.240
+6.950+8.25%

關於 GeneDx Holdings Corp 公司

GeneDx Holdings Corp. is a genomics company. The Company operates, through its subsidiary, GeneDx, LLC, which is focused on exome and genome tests that translate complex genomic data into clinical answers that unlock personalized health plans, accelerate drug discovery, and improve health system efficiencies. It operates through GeneDx segment, which primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. Exome sequencing test options include XomeDx, XomeDx Plus, and XomeDxXpress. GeneDx genome sequencing evaluates the protein-coding and non-coding regions of an individual’s nuclear genome. GeneDx genome sequencing test options include GenomeSeqDx and GenomeXpress. It offers a menu of targeted variant testing options to meet the needs of families and healthcare providers. Its subsidiary, Fabric Genomics, Inc., specializes in artificial intelligence-powered genomic interpretation.

GeneDx Holdings Corp簡介

公司代碼WGS
公司名稱GeneDx Holdings Corp
上市日期Sep 04, 2020
CEOStueland (Katherine A)
員工數量1000
證券類型Ordinary Share
年結日Sep 04
公司地址333 Ludlow Street
城市STAMFORD
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編06902
電話18887291206
網址https://sema4.com/
公司代碼WGS
上市日期Sep 04, 2020
CEOStueland (Katherine A)

GeneDx Holdings Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+12924.00%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+12924.00%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.43K
+437.00%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-16553.00%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
名稱
名稱/職務
職務
持股
持股變動
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+12924.00%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+12924.00%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
9.43K
+437.00%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-16553.00%
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--

收入明細

單位: USD更新時間: 1月6日 週二
單位: USD更新時間: 1月6日 週二
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
業務USD
名稱
營收
佔比
Patients with third party insurance
95.02M
81.39%
Institutional customers
17.87M
15.31%
Other
3.22M
2.76%
Self pay patients
629.00K
0.54%
由於公司未披露,未能獲取相關數據
業務
地區
業務USD
名稱
營收
佔比
Patients with third party insurance
95.02M
81.39%
Institutional customers
17.87M
15.31%
Other
3.22M
2.76%
Self pay patients
629.00K
0.54%

股東統計

更新時間: 1月31日 週六
更新時間: 1月31日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
其他
64.96%
持股股東
持股股東
佔比
Corvex Management LP
10.58%
Casdin Capital, LLC
10.40%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
BlackRock Institutional Trust Company, N.A.
4.56%
其他
64.96%
股東類型
持股股東
佔比
Investment Advisor
32.95%
Investment Advisor/Hedge Fund
32.14%
Hedge Fund
30.92%
Corporation
10.65%
Research Firm
6.77%
Individual Investor
1.69%
Pension Fund
0.74%
Venture Capital
0.31%
Sovereign Wealth Fund
0.29%

機構持股

更新時間: 1月21日 週三
更新時間: 1月21日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q4
456
30.28M
113.16%
--
2025Q4
500
30.62M
105.95%
-3.52M
2025Q3
446
32.52M
112.51%
-918.42K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
查看更多

股東持股明細

名稱
持股數
佔比
持股變動
變動比例
公告日期
Corvex Management LP
3.06M
10.58%
--
--
Sep 30, 2025
Casdin Capital, LLC
3.01M
10.4%
-38.49K
-1.26%
Sep 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.75%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.74%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.32M
4.56%
+37.99K
+2.97%
Sep 30, 2025
The Vanguard Group, Inc.
1.17M
4.03%
-10.50K
-0.89%
Sep 30, 2025
Goldman Sachs & Company, Inc.
1.00M
3.47%
+28.59K
+2.94%
Sep 30, 2025
Oracle Investment Management, Inc.
889.95K
3.08%
-32.50K
-3.52%
Sep 30, 2025
Summit Partners Public Asset Management, LLC
823.57K
2.85%
+56.30K
+7.34%
Sep 30, 2025
William Blair Investment Management, LLC
1.22M
4.22%
-411.26K
-25.21%
Sep 30, 2025
查看更多

持股ETF

更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X Genomics & Biotechnology ETF
3.84%
Franklin Genomic Advancements ETF
3.47%
Clough Hedged Equity ETF
2.89%
Clough Select Equity ETF
2.65%
State Street SPDR S&P Health Care Services ETF
2.27%
Harbor Health Care ETF
1.85%
Innovator IBD Breakout Opportunities ETF
1.52%
ARK Genomic Revolution ETF
1.29%
Main Thematic Innovation ETF
1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
1.18%
查看更多
Global X Genomics & Biotechnology ETF
佔比3.84%
Franklin Genomic Advancements ETF
佔比3.47%
Clough Hedged Equity ETF
佔比2.89%
Clough Select Equity ETF
佔比2.65%
State Street SPDR S&P Health Care Services ETF
佔比2.27%
Harbor Health Care ETF
佔比1.85%
Innovator IBD Breakout Opportunities ETF
佔比1.52%
ARK Genomic Revolution ETF
佔比1.29%
Main Thematic Innovation ETF
佔比1.29%
Invesco Dorsey Wright Healthcare Momentum ETF
佔比1.18%

分紅派息

近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據

拆合股

公告日期
除權除息日
類型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
公告日期
除權除息日
類型
比率
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI